RWM
CDMO

RBA Wealth Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

RBA Wealth Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-29
Closed -$529 – 224
2021
Q1 		$529 Buy
+29
New +$482 ﹤0.01% 228

Other funds holding CDMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RBA Wealth Management's CDMO Position: Q2 2021 in Review

RBA Wealth Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2021, closing a stake of 29 shares — an estimated $529 sold.

RBA Wealth Management first reported a position in CDMO in Q1 2021 and held it in 1 quarter. The position peaked at $529 in Q1 2021. 172 funds tracked by Wall St. Rank hold CDMO as of Q2 2021.

  • RBA Wealth Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • RBA Wealth Management sold 29 Avid Bioservices, Inc. Common Stock shares in Q2 2021, an estimated $529.
  • RBA Wealth Management first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • RBA Wealth Management's Avid Bioservices, Inc. Common Stock position peaked at $529 in Q1 2021.
  • 172 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2021.

Based on RBA Wealth Management's 13F filing for Q2 2021, filed 22 Jul 2021.